Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1546 of 6351
-
SEAL brain health under scrutiny: new study aims to detect hidden blast injuries
Knowledge-focused Recruiting nowThis is a 4-year, longitudinal study of 100 active-duty Navy SEALs. The goal of the study is to determine whether repeated blast exposure affects SEAL brain health and to develop an initial diagnostic testing protocol that detects repeated blast brain injury.
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New peptide drug hopes to boost brain repair after stroke
Disease control Recruiting nowThis is a randomized, double-blinded, placebo-controlled study investigating the safety and efficacy of QD202 injection in patients with acute ischemic stroke undergoing thrombolysis excluding endovascular thrombectomy. Up to 120 male and female patients with acute ischemic strok…
Phase 2 • Sponsor: Shanghai QuietD Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New insulin method aims to protect kidneys in diabetes patients
Disease control Recruiting nowThe purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).
Sponsor: Well Cell Global • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Stool test could stop Crohn's Flare-Ups after surgery
Disease control Recruiting nowCrohn's disease (CD) (\> 200,000 patients in France) is a chronic inflammatory disease that can lead to progression of intestinal destruction and impaired quality of life. Despite the widespread use of biotherapies, intestinal resections remain frequent (50% of patients over time…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
One-hour talk before c-section may stop postpartum anxiety and trauma
Prevention Recruiting nowPerinatal mental health disorders are the most prevalent perinatal comorbidity and are associated with the primary cause of maternal mortality in the United States (US) - suicide. Diagnosis of a high-risk pregnancy and cesarean delivery (CD) are both associated with increased ris…
Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New flu vaccine trial aims to protect moms and babies
Vaccine Recruiting nowThis is a randomized, double-blind, positive controlled phase Ⅲ clinical trial to assess the immunogenicity and safety of Sinovac QIV in pregnant women. A total of 150 healthy pregnant women aged 18\~39 years at 20 to 32 weeks of pregnancy will be enrolled. All participants will …
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 09:00 UTC
-
New Single-Dose flu drug shows promise in kids trial
Disease control CompletedThe goal of this phase III study is to learn if ZX-7101A for oral suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years. The main question it aims to answer is: What medical problems do participants have when taking drug ZX-7101A for oral…
Phase 3 • Sponsor: Nanjing Zenshine Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New heart procedure aims to cut AFib relapse rates in half
Disease control Recruiting nowAtrial fibrillation (AF) is one of the most common cardiac arrhythmias worldwide, associated with high morbidity and mortality rates. Epidemiological studies in China show that the prevalence of AF in individuals aged ≥60 years ranges from 2% to 3%, with rates continuing to rise …
Sponsor: Zhibing Lu • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New inhaled TB drug shows promise in early trial
Disease control Recruiting nowA Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of Nebulised RESP30TB in Adults with Newly Diagnosed, Rifampicin Susceptible Pulmonary Tuberculosis
Phase 2 • Sponsor: Thirty Respiratory Limited • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New group therapy aims to rewire depressed brains
Symptom relief Recruiting nowMajor depressive disorder (MDD) is one of the most common psychiatric conditions and often remains difficult to treat effectively. Many patients continue to experience residual symptoms or relapse even after receiving established forms of psychotherapy. This study tests whether t…
Sponsor: Philipps University Marburg • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Pharmacists step in to tackle diabetes crisis
Disease control Recruiting nowAs of 2024, nine percent of Albertans are living with Type 2 diabetes, which increases their risk for cardiovascular disease, stroke, blindness, and kidney failure. Unfortunately, less than half of patients have controlled Type 2 diabetes. We are well aware of the factors which l…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Supercharged baby formula may boost brain growth in Heart-Disease infants
Disease control Recruiting nowThe purpose of this study is to compare the effect of high and ordinary energy density enteral nutrition for improving physical growth and brain cognitive development in infants with congenital heart disease after operation, as well as evaluate the safety of interventions.
Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Stress relief for refugee families: a new hope for mothers and kids
Symptom relief OngoingThis study evaluates whether the group-based mental health program Self-Help Plus (SH+) can improve the mental health, wellbeing, and functioning of refugee mothers and their preschool-aged children living in Rhino Refugee Settlement (Rhino Camp), Uganda. SH+ is a stress manageme…
Sponsor: Uppsala University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can virtual reality teach CPR as well as a manikin?
Knowledge-focused CompletedThis study compared two methods for teaching cardiopulmonary resuscitation (CPR) to undergraduate medical students: immersive virtual reality and manikin-based simulation. A total of 129 medical students participated in the study and were assigned to either the immersive virtual …
Sponsor: Shiraz University of Medical Sciences • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Mini lung machine tested on tiniest patients
Disease control Recruiting nowThis prospective observational study will evaluate the safety and performance of the MiniLung petite kit in neonatal and pediatric patients with acute respiratory and cardiac failure. The main question it aims to answer is (study hypotheses): Veno-venous (VV) and veno-arterial …
Sponsor: Xenios AG • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New heart pump could help High-Risk patients during angioplasty
Disease control Recruiting nowThe objective of this study is to assess the safety and feasibility of the Supira System in heart failure patients with low LVEF, undergoing HRPCI with use of mechanical circulatory support who may benefit from cardiovascular hemodynamic support beyond the PCI procedure.
Sponsor: Supira Medical • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a beam of light boost acne treatment?
Disease control CompletedThis randomized, evaluator-blinded, split-face study evaluated whether adjunctive lesion-directed 308-nm excimer light improves inflammatory acne outcomes during oral azithromycin therapy. All participants received oral azithromycin 500 mg three times weekly for 8 weeks. One rand…
Sponsor: Mahmoud Rageh • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Balloon catheter could boost stroke recovery in one go
Disease control Recruiting nowTo investigate whether using balloon guide catheter with flow arrest during mechanical thrombectomy, compared to non-flow arrest, improves the rate of first pass expanded Thrombolysis in Cerebral Infarction score (eTICI 2c-3) reperfusion for acute ischemic stroke due to internal …
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
AI aims to uncover hidden barriers to stroke care
Knowledge-focused By invitation onlyThis study aims to identify and quantify the non-clinical barriers (social, transport, and knowledge-based) that delay patient arrival at the hospital during an Acute Ischemic Stroke. By utilizing a multimodal approach that combines a validated patient questionnaire (SABI Tool), …
Sponsor: Middle East North Africa Stroke and Interventional Neurotherapies Organization • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Heart failure fluid battle: which pill works better?
Disease control Recruiting nowThis clinical trial aims to compare the efficacy and safety of acetazolamide versus metolazone as adjunctive treatments to standard therapy in patients with acute decompensated heart failure (ADHF). ADHF is a life-threatening condition, and current treatments often involve loop d…
Sponsor: University of Health Sciences Lahore • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC